AAAAAA
Results: 1-25/27
Authors:
LAMHARZI N
HALMOS G
JUNGWIRTH A
SCHALLY AV
Citation: N. Lamharzi et al., DECREASE IN THE LEVEL AND MESSENGER-RNA EXPRESSION OF LH-RH AND EGF RECEPTORS AFTER TREATMENT WITH LH-RH ANTAGONIST CETRORELIX IN DU-145 PROSTATE TUMOR XENOGRAFTS IN NUDE-MICE, International journal of oncology, 13(3), 1998, pp. 429-435
Authors:
FRICK J
JUNGWIRTH A
ROVAN E
KALLA N
Citation: J. Frick et al., THE PILL FOR MEN - UPDATE ON FERTILITY-CO NTROL IN MEN, Gynakologisch-geburtshilfliche Rundschau, 38(1), 1998, pp. 50-53
Authors:
SCHALLY AV
JUNGWIRTH A
COMARUSCHALLY AM
Citation: Av. Schally et al., COMMENTS ON INHIBITION OF GROWTH OF ANDROGEN-INDEPENDENT DU-145 PROSTATE-CANCER IN-VIVO BY LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONISTCETRORELIX AND BOMBESIN ANTAGONISTS RC-3940-II AND RC-3950-II, JUNGWIRTH ET-AL., EUR J CANCER 1997, 33(7), 1141-1148 - RESPONSE, European journal of cancer, 34(7), 1998, pp. 1135-1136
Authors:
JUNGWIRTH A
GOMAHR A
JOOS H
FRICK J
MOOYOUNG AJ
NASH H
SCHLEGEL PN
KUZMA P
BARDIN CW
Citation: A. Jungwirth et al., POTENT LHRH-AGONIST FOR TESTOSTERONE DEPRIVATION (NEW MODE OF APPLICATION), The Journal of urology, 159(5), 1998, pp. 494-494
Authors:
JUNGWIRTH A
FRICK J
SCHALLY AV
HALMOS G
GROOT K
SZEPESHAZI K
PINSKI J
Citation: A. Jungwirth et al., SOMATOSTATIN ANALOG RC-160, LH-RH ANTAGONIST CETRORELIX AND BOMBESIN ANTAGONIST RC-3940-II INHIBIT GROWTH OF CAKI-1 HUMAN RENAL-CARCINOMA, The Journal of urology, 159(5), 1998, pp. 727-727
Authors:
JUNGWIRTH A
SCHALLY AV
HALMOS G
GROOT K
SZEPESHAZI K
PINSKI J
ARMATIS P
Citation: A. Jungwirth et al., INHIBITION OF THE GROWTH OF CAKI-I HUMAN RENAL ADENOCARCINOMA IN-VIVOBY LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX, SOMATOSTATIN ANALOG RC-160, AND BOMBESIN ANTAGONIST RC-3940-II, Cancer, 82(5), 1998, pp. 909-917
Authors:
JUNGWIRTH A
SCHALLY AV
NAGY A
PINSKI J
GROOT K
GALVAN G
SZEPESHAZI K
HALMOS G
Citation: A. Jungwirth et al., REGRESSION OF RAT DUNNING R-3327-H PROSTATE CARCINOMA BY TREATMENT WITH TARGETED CYTOTOXIC ANALOG OF LUTEINIZING-HORMONE-RELEASING HORMONE AN-207 CONTAINING 2-PYRROLINODOXORUBICIN, International journal of oncology, 10(5), 1997, pp. 877-884
Authors:
JUNGWIRTH A
PINSKI J
GALVAN G
HALMOS G
SZEPESHAZI K
CAI RZ
GROOT K
VADILLOBUENFIL M
SCHALLY AV
Citation: A. Jungwirth et al., INHIBITION OF GROWTH OF ANDROGEN-INDEPENDENT DU-145 PROSTATE-CANCER IN-VIVO BY LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX AND BOMBESIN ANTAGONISTS RC-3940-II AND RC-3950-II, European journal of cancer, 33(7), 1997, pp. 1141-1148
Authors:
MACK D
JUNGWIRTH A
ADAM U
KUNIT G
MILLER K
DIETZE O
FRICK J
Citation: D. Mack et al., LONG-TERM FOLLOW-UP AFTER OPEN PERINEAL CRYOTHERAPY IN PATIENTS WITH LOCALLY CONFINED PROSTATE-CANCER, European urology, 32(2), 1997, pp. 129-132
Authors:
JUNGWIRTH A
GALVAN G
PINSKI J
HALMOS G
SZEPESHAZI K
CAI RZ
GROOT K
SCHALLY AV
Citation: A. Jungwirth et al., LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX (SB-75) AND BOMBESIN ANTAGONIST RC-3940-II INHIBIT THE GROWTH OF ANDROGEN-INDEPENDENT PC-3 PROSTATE-CANCER IN NUDE-MICE, The Prostate, 32(3), 1997, pp. 164-172
Authors:
FUERST J
FIEBIGER E
JUNGWIRTH A
MACK D
TALWAR PG
FRICK J
ROVAN E
Citation: J. Fuerst et al., EFFECT OF ACTIVE IMMUNIZATION AGAINST LUTEINIZING-HORMONE-RELEASING HORMONE ON THE ANDROGEN-SENSITIVE DUNNING R3327-PAP AND ANDROGEN-INDEPENDENT DUNNING R3327-AT2.1 PROSTATE-CANCER SUBLINES, The Prostate, 32(2), 1997, pp. 77-84
Authors:
DATZ C
JUNGWIRTH A
DUSCH H
GALVAN G
WEIGER T
Citation: C. Datz et al., WHATS ON DOCTORS BALL POINT PENS, Lancet, 350(9094), 1997, pp. 1824-1824
Authors:
JUNGWIRTH A
SCHALLY AV
PINSKI J
GROOT K
ARMATIS P
HALMOS G
Citation: A. Jungwirth et al., GROWTH HORMONE-RELEASING HORMONE ANTAGONIST MZ-4-71 INHIBITS IN-VIVO PROLIFERATION OF CAKI-I RENAL ADENOCARCINOMA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(11), 1997, pp. 5810-5813
Authors:
GOMAHR A
KUNIT G
JUNGWIRTH A
MACK D
FRICH J
Citation: A. Gomahr et al., INTERNATIONAL-CONFERENCE ON PEYRONIES-DISEASE - ADVANCES IN BASIC ANDCLINICAL RESEARCH, The Journal of urology, 158(6), 1997, pp. 2251-2252
Authors:
RAMON J
LYNCH TH
EARDLEY I
EKMAN P
FRICK J
JUNGWIRTH A
PILLAI M
WIKLUND P
GOLDWASSER B
FITZPATRICK JM
Citation: J. Ramon et al., TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - A COLLABORATIVE MULTICENTER STUDY, British Journal of Urology, 80(1), 1997, pp. 128-134
Authors:
JUNGWIRTH A
SCHALLY AV
PINSKI J
HALMOS G
GROOT K
ARMATIS P
VADILLOBUENFIL M
Citation: A. Jungwirth et al., INHIBITION OF IN-VIVO PROLIFERATION OF ANDROGEN-INDEPENDENT PROSTATE CANCERS BY AN ANTAGONIST OF GROWTH HORMONE-RELEASING HORMONE, British Journal of Cancer, 75(11), 1997, pp. 1585-1592
Authors:
JUNGWIRTH A
WEIGER T
SINGH SK
PAULMICHL M
FRICK J
Citation: A. Jungwirth et al., FOLLICLE-STIMULATING-HORMONE ACTIVATES A CAMP-DEPENDENT CHLORIDE CONDUCTANCE IN TM4 SERTOLI CELLS, Biochemical and biophysical research communications, 233(1), 1997, pp. 203-206
Authors:
PINSKI J
SCHALLY AV
JUNGWIRTH A
GROOT K
HALMOS G
ARMATIS P
ZARANDI M
VADILLOBUENFIL M
Citation: J. Pinski et al., INHIBITION OF GROWTH OF HUMAN SMALL-CELL AND NONSMALL CELL LUNG CARCINOMAS BY ANTAGONISTS OF GROWTH HORMONE-RELEASING HORMONE (GH-RH), International journal of oncology, 9(6), 1996, pp. 1099-1105
Authors:
PINSKI J
IZDEBSKI J
JUNGWIRTH A
GROOT K
SCHALLY AV
Citation: J. Pinski et al., EFFECT OF CHRONIC ADMINISTRATION OF A NEW POTENT AGONIST OF GH-RH(1-29)NH2 ON LINEAR GROWTH AND GH RESPONSIVENESS IN RATS, Regulatory peptides, 65(3), 1996, pp. 197-201
Authors:
WOLL E
GSCHWENTNER M
FURST J
HOFER S
BUEMBERGER G
JUNGWIRTH A
FRICK J
DEETJEN P
PAULMICHL M
Citation: E. Woll et al., FLUORESCENCE-OPTICAL MEASUREMENTS OF CHLORIDE MOVEMENTS IN CELLS USING THE MEMBRANE-PERMEABLE DYE DIH-MEQ, Pflugers Archiv, 432(3), 1996, pp. 486-493
Authors:
NAGY A
SCHALLY AV
ARMATIS P
SZEPESHAZI K
HALMOS G
KOVACS M
ZARANDI M
GROOT K
MIYAZAKI M
JUNGWIRTH A
HORVATH J
Citation: A. Nagy et al., CYTOTOXIC ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE-CONTAININGDOXORUBICIN OR 2-PYRROLINODOXORUBICIN, A DERIVATIVE 500-1000 TIMES MORE POTENT, Proceedings of the National Academy of Sciences of the United Statesof America, 93(14), 1996, pp. 7269-7273
Authors:
ARRER E
JUNGWIRTH A
MACK D
FRICK J
PATSCH W
Citation: E. Arrer et al., TREATMENT OF PROSTATE-CANCER WITH GONADOTROPIN-RELEASING-HORMONE ANALOG - EFFECT ON LIPOPROTEIN[A], The Journal of clinical endocrinology and metabolism, 81(7), 1996, pp. 2508-2511
Authors:
PINSKI J
LAMHARZI N
HALMOS G
GROOT K
JUNGWIRTH A
VADILLOBUENFIL M
KAKAR SS
SCHALLY AV
Citation: J. Pinski et al., CHRONIC ADMINISTRATION OF THE LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) ANTAGONIST CETRORELIX DECREASES GONADOTROPE RESPONSIVENESS AND PITUITARY LHRH RECEPTOR MESSENGER-RIBONUCLEIC-ACID LEVELS IN RATS, Endocrinology, 137(8), 1996, pp. 3430-3436
Authors:
GSCHWENTNER M
JUNGWIRTH A
HOFER S
WOLL E
RITTER M
SUSANNA A
SCHMARDA A
REIBNEGGER G
PINGGERA GM
LEITINGER M
FRICK J
DEETJEN P
PAULMICHL M
Citation: M. Gschwentner et al., BLOCKADE OF SWELLING-INDUCED CHLORIDE CHANNELS BY PHENOL DERIVATIVES, British Journal of Pharmacology, 118(1), 1996, pp. 41-48
Authors:
GSCHWENTNER M
SUSANNA A
HOFER S
JUNGWIRTH A
FRICK J
PAULMICHL M
Citation: M. Gschwentner et al., THE PHENOL DERIVATIVES GOSSYPOL AND NDGA BLOCK CHLORIDE CHANNELS ACTIVATED AFTER CELL SWELLLNG, Biophysical journal, 70(2), 1996, pp. 213-213